Company / Return on Equity (ROE)
InspireMD, Inc. Return on Equity (ROE) History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Equity (ROE)
-88.7%
FY2025
5-year range
-106.3% / -44.5%
FY2021-FY2025
Trend
-75.9%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
InspireMD, Inc. reports negative total equity of -88.7% in FY2025. Negative equity can occur when accumulated losses exceed contributed capital, as reported in the balance sheet from the SEC filing.
Based on SEC 10-K filings.
-88.7% in FY2025 with a 5-year CAGR of +97.8%.
Improved from -106.3% to -88.7% over the past 2 years.
Return on Equity (ROE) over time
Growth rates
- 3-Year Change
- -44.2pp
- 5-Year Change
- +97.8pp
- 10-Year Change
- -
Key checks
Key Insights
- In FY2025, return on equity (roe) decreased 75.9% year-over-year.
- Peak return on equity (roe) was recorded in FY2022.
- Lowest return on equity (roe) in the period was in FY2018.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -0.42 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Equity (ROE)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -88.7% | -75.9% |
| FY2024 | -50.4% | +52.6% |
| FY2023 | -106.3% | -139.0% |
| FY2022 | -44.5% | +48.7% |
| FY2021 | -86.7% | +53.5% |
| FY2020 | -186.5% | -125.7% |
| FY2019 | -82.6% | +73.3% |
| FY2018 | -309.4% | -47.9% |
| FY2017 | -209.2% | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026